Haloford 1ml Injection

Haloford 1ml Injection contains Haloperidol 5mg/ML, a typical antipsychotic medication used to manage symptoms of schizophrenia, acute psychosis, and severe agitation.

Benefits

Haloperidol 5mg/ML Injection provides rapid control of severe symptoms in mental and behavioral disorders. It is particularly useful when oral medications are not feasible or when immediate intervention is required for acute agitation or psychotic episodes.

Uses and Indications

• Management of schizophrenia.
• Control of tics and vocal utterances in Tourette's syndrome.
• Treatment of acute psychosis and severe agitation.
• Management of other psychotic disorders and severe behavioral disturbances.

The Haloford 1ml Injection contains:

• Haloperidol 5mg/ML (as lactate) (active ingredient).
• Excipients: methylparaben, propylparaben, lactic acid (to adjust pH), and Water for Injection.

Dosage and Administration

1. Haloperidol 5mg/ML Injection is typically administered by deep intramuscular (IM) injection.
2. For acute conditions, a dose of 2 mg to 10 mg may be given intramuscularly, with subsequent doses administered hourly based on patient response and tolerability, up to a maximum of 20 mg daily.
3. The exact dosage and treatment duration must be determined by a qualified healthcare provider based on the patient's clinical condition.
4. Intravenous administration is not FDA approved and requires close ECG monitoring due to potential cardiac risks.

Storage and Disposal

• Store the injection below 30°C.
• Protect from light and moisture.
• Do not freeze.
• Keep out of reach of children and pets.
• Discard any unused portion properly after use.

Precautions and Safety

• Use with caution in patients with a history of heart disease, seizures, Parkinson's disease, or severe central nervous system depression.
• Avoid alcohol consumption during treatment, as it can increase sedation and other side effects.
• Do not drive or operate machinery until you know how this medication affects you, as it may cause drowsiness, dizziness, or blurred vision.
• Sudden discontinuation can lead to withdrawal symptoms; dosage should be reduced gradually under medical supervision.
• Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death; Haloperidol injection is not approved for this condition.
• Monitor for movement disorders, cardiac effects (QT prolongation), and overall tolerability.

Side Effects and Risks

• Common side effects include drowsiness, dizziness, dry mouth, blurred vision, constipation, and tremors.
• Serious side effects may include extrapyramidal symptoms (tremors, rigidity, involuntary movements), tardive dyskinesia (involuntary movements of the face, tongue, or other body parts), and neuroleptic malignant syndrome (fever, stiff muscles, confusion).
• Cardiac effects such as QT prolongation and Torsades de Pointes can occur, especially with high doses or intravenous use.
• Other reported side effects include orthostatic hypotension, rash, and visual disturbances.

Disclaimer

Use this medicine only under the prescription and guidance of a qualified doctor or pharmacist.